Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

F2G Ltd: $70m Financing Led by Forbion & Sofinnova Partners (2022-08-04)
New Investment from Forbion and Sofinnova Partners F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical need, today announces ...
Forty51 Ventures Announces First $43m Close of Fund I (2022-07-18)
FORTY51 Ventures today announced the closing of FORTY51 Ventures I, raising USD 43 Million in its first close. FORTY51's core strategy focuses on company formation and early stage investments in Biotech with geographic emphasis on Switzerland, France and German...
Enterome: R&D Collaboration with Nestlé Health Science (2022-07-18)
>Enterome and Nestlé Health Science will co-develop Enterome’s lead EndoMimics™ compound, EB1010, a potent local inducer of IL-10 targeting food allergies and inflammatory bowel disease (IBD). EB1010 is due to enter clinical trials in 2023. > The collaboration w...
Mosanna Therapeutics Announces Seed Financing Round (2022-07-13)
> Company pursuing an advanced small molecule MOS-118 (formerly known as AVE0118) discovered by Sanofi. > Experienced team with strong background in Metabolic Diseases and Obstructive Sleep Apnea. > Seed financing led by Forty51 Ventures. Mosanna Therap...
Jan Van den Bossche Joins Andera Partners Life Sciences Team (2022-07-07)
Jan Van den Bossche joins the Andera Life Sciences team as a partner to accelerate the deployment of its BioDiscovery 6 fund Andera Partners strengthens its organization by welcoming Jan Van den Bossche as a partner within Andera Life Sciences, its team speciali...
Biosyntia Closes €11.5m Series B Round Led by ECBF (2022-07-07)
> ECBF invests in its 8th portfolio company, Biosyntia ApS from Denmark > Biosyntia is a precision fermentation company focused on replacing a fossil-based production process with a bio-based one for products such as vitamins and other ingredients > ECBF join...
Ganymed Robotics: €21m First Close of Series B Led by Cathay (2022-07-07)
> The oversubscribed first close of Series B funding was led by Cathay Health, joined by Credit Mutuel Innovation, Kurma Partners and BNP Paribas Développement. > Funds will accelerate the execution of the Company’s product development towards a new standard of ...
Evotec, Boehringer & bioMérieux Launch AMR Joint Venture (2022-07-06)
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO), Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a joint...
Urovant Sciences Licenses Vibegron to Pierre Fabre (2022-07-05)
> Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the European Economic Area, UK, and Switzerland. > Urovant Sciences GmbH to receive compensation of up to USD $75 million in upfr...
ReCode Therapeutics Closes $120m Series B Extension (2022-06-29)
– Series B extension co-led by AyurMaya, an affiliate of Matrix Capital Management, and Leaps by Bayer, with participation from Amgen Ventures. Adds to Existing Investors, including Pfizer Ventures, EcoR1 Capital and Sanofi Ventures. – – Proceeds to expand and d...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Made Without Love 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)